These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29695350)

  • 1. Plotting a route to a universal influenza vaccine.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2018 May; 18(5):475. PubMed ID: 29695350
    [No Abstract]   [Full Text] [Related]  

  • 2. Pandemic 2009-2010 influenza vaccine: six lessons learned and the way forward (Allegro not Adagio).
    Poland GA
    Vaccine; 2011 Jan; 29(4):613-4. PubMed ID: 21193121
    [No Abstract]   [Full Text] [Related]  

  • 3. Universal influenza vaccines: a realistic option?
    de Vries RD; Altenburg AF; Rimmelzwaan GF
    Clin Microbiol Infect; 2016 Dec; 22 Suppl 5():S120-S124. PubMed ID: 27130671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza: options to improve pandemic preparation.
    Rappuoli R; Dormitzer PR
    Science; 2012 Jun; 336(6088):1531-3. PubMed ID: 22723412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2012-2013 influenza update: hitting a rapidly moving target.
    Jin XW; Mossad SB
    Cleve Clin J Med; 2012 Nov; 79(11):777-84. PubMed ID: 23125327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2011 Oct; 86(43):469-80. PubMed ID: 22046595
    [No Abstract]   [Full Text] [Related]  

  • 7. The 2009 Provincial decision to de-emphasize seasonal influenza vaccine in Canada: real-time risk-benefit analysis.
    Kendall PR
    Clin Infect Dis; 2011 Mar; 52(6):829-30; author reply 830-1. PubMed ID: 21367739
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-effectiveness of Ontario's pandemic vaccine program.
    Rolland-Harris E; Tepper M
    Vaccine; 2011 May; 29(22):3829; author reply 3830-1. PubMed ID: 20831912
    [No Abstract]   [Full Text] [Related]  

  • 9. Head-to-head comparison of pandemic influenza vaccines.
    Leroux-Roels G; Leroux-Roels I
    Lancet Infect Dis; 2011 Feb; 11(2):74-5. PubMed ID: 21168368
    [No Abstract]   [Full Text] [Related]  

  • 10. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2012 Oct; 87(42):401-12. PubMed ID: 23113329
    [No Abstract]   [Full Text] [Related]  

  • 11. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2012 Mar; 87(11):97-108. PubMed ID: 22462204
    [No Abstract]   [Full Text] [Related]  

  • 12. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2013 Oct; 88(42):449-63. PubMed ID: 24159668
    [No Abstract]   [Full Text] [Related]  

  • 13. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2014 Mar; 89(11):105-15. PubMed ID: 24707515
    [No Abstract]   [Full Text] [Related]  

  • 14. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2013 Mar; 88(11):117-25. PubMed ID: 23544238
    [No Abstract]   [Full Text] [Related]  

  • 15. Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010).
    Hanquet G; Van Damme P; Brasseur D; De Cuyper X; Gregor S; Holmberg M; Martin R; Molnár Z; Pompa MG; Snacken R; van der Sande M; Van Ranst M; Wirtz A; Neels P
    Vaccine; 2011 Jan; 29(3):370-7. PubMed ID: 21075164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of the safety and immunogenicity of H5N1 pandemic influenza vaccines.
    Leroux-Roels I
    Bull Mem Acad R Med Belg; 2011; 166(1-2):18-24. PubMed ID: 22375487
    [No Abstract]   [Full Text] [Related]  

  • 17. Cross-clade immunogenicity and antigen-sparing with an AS03(A)-adjuvanted prepandemic influenza vaccine in a Thai population.
    Thongcharoen P; Auewarakul P; Hutagalung Y; Ong G; Gillard P; Drame M; Bock HL
    J Med Assoc Thai; 2011 Aug; 94(8):916-26. PubMed ID: 21863672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seasonal influenza vaccination and the 2009 pandemic.
    Mercer G; Kelly H
    Clin Infect Dis; 2011 Mar; 52(6):828-9; author reply 830-1. PubMed ID: 21367738
    [No Abstract]   [Full Text] [Related]  

  • 19. INFLUENZA. Narcolepsy link to pandemic flu vaccine becomes clearer.
    Vogel G
    Science; 2015 Jul; 349(6243):17. PubMed ID: 26138959
    [No Abstract]   [Full Text] [Related]  

  • 20. The imperative of influenza vaccines for elderly individuals-an evolving story.
    Poland GA; Mulligan MJ
    J Infect Dis; 2009 Jul; 200(2):161-3. PubMed ID: 19508160
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.